| 000 | 01633 a2200433 4500 | ||
|---|---|---|---|
| 005 | 20250515054259.0 | ||
| 264 | 0 | _c20070504 | |
| 008 | 200705s 0 0 eng d | ||
| 022 | _a1521-6616 | ||
| 024 | 7 |
_a10.1016/j.clim.2006.12.002 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aLink, Jason M | |
| 245 | 0 | 0 |
_aMonomeric DR2/MOG-35-55 recombinant TCR ligand treats relapses of experimental encephalomyelitis in DR2 transgenic mice. _h[electronic resource] |
| 260 |
_bClinical immunology (Orlando, Fla.) _cApr 2007 |
||
| 300 |
_a95-104 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S. | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aEncephalomyelitis, Autoimmune, Experimental _ximmunology |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aGlycoproteins _xgenetics |
| 650 | 0 | 4 |
_aHLA-DR2 Antigen _xgenetics |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aLigands |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 | _aMice, Transgenic |
| 650 | 0 | 4 | _aMyelin-Oligodendrocyte Glycoprotein |
| 650 | 0 | 4 |
_aPeptide Fragments _xgenetics |
| 650 | 0 | 4 |
_aReceptors, Antigen, T-Cell _xagonists |
| 650 | 0 | 4 |
_aRecombinant Proteins _xadministration & dosage |
| 650 | 0 | 4 | _aSecondary Prevention |
| 700 | 1 | _aRich, Cathleen M | |
| 700 | 1 | _aKorat, Maya | |
| 700 | 1 | _aBurrows, Gregory G | |
| 700 | 1 | _aOffner, Halina | |
| 700 | 1 | _aVandenbark, Arthur A | |
| 773 | 0 |
_tClinical immunology (Orlando, Fla.) _gvol. 123 _gno. 1 _gp. 95-104 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.clim.2006.12.002 _zAvailable from publisher's website |
| 999 |
_c16819774 _d16819774 |
||